The 16 analysts offering 12-month price forecasts for Incyte Corp have a median target of 92.50, with a high estimate of 136.00 and a low estimate of 66.00. The median estimate represents a +38.78% increase from the last price of 66.65.
The current consensus among 20 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.58
Reporting Date Feb 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.